Latest News

Date Title Topic
08 May 2015 IMPAKT 2015 News: Molecular Screening of Patients with Metastatic Breast Cancer Can Be Carried-Out Across EU Countries Breast cancer - Personalised medicine
07 May 2015 IMPAKT 2015 News: PI3 Kinase and CDK4/6 Inhibitors Are Highly Active in ER-Positive Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
07 May 2015 IMPAKT 2015 News: A Circulating Tumour Cell Liquid Biopsy May Be Used for Non-Invasive Mutational Analysis in Patients with Breast Cancer Breast cancer - Translational research
07 May 2015 IMPAKT 2015 News: Constitutively Activated STAT3 May Be a Predictive Marker for Resistance to Trastuzumab in Patients with HER2 Positive Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
07 May 2015 IMPAKT 2015 News: Gene Expression Signatures May Signal Clinical Activity of Palbociclib in Patients with Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
Programme
28 Apr 2015 European Medicine Agency Recommends Refusal of the Marketing Authorisation for Dasiprotimut-T Haematologic malignancies - Cancer Immunology and Immunotherapy
27 Apr 2015 FDA Approves Ramucirumab for Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
24 Apr 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Nivolumab Melanoma - Cancer Immunology and Immunotherapy
22 Apr 2015 Pembrolizumab Shows Antitumour Activity in Patients with Advanced NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
21 Apr 2015 Phase III Randomised Trial Shows Pembrolizumab Superiority When Compared to Ipilimumab in Patients with Advanced Melanoma Melanoma - Cancer Immunology and Immunotherapy
Consensus Guidelines Locally-advanced stage III non-small-cell lung cancer (NSCLC)
17 Apr 2015 ELCC 2015 News: Circulating Tumour Cells May Be a Prognostic Marker for Disease Recurrence Following Radical Resection in Patients with NSCLC Translational research - Lung and other thoracic tumours
17 Apr 2015 ELCC 2015 Press Release: One in Four Advanced Lung Cancer Patients Tested for EGFR Mutations Started on First-line Treatment Before Test Results Available Bioethics, legal and economic issues - Lung and other thoracic tumours
17 Apr 2015 ELCC 2015 Press Release: DNA Blood Test Detects Lung Cancer Mutations Translational research - Lung and other thoracic tumours